8/12/2019 Incourse Question(2)

1/2

Intellectual Property, Ethics and Legal Issues [CT031-3-2 IPEL]

Question

rticle 2! o" the T#IP$ gree%ent ena&les phar%aceutical co%panies to o'n a patent "ordrugs (%edicine), usually "or up to 20 years* Patent protection and e+tensions are usti"ied

&ecause a large part of that (patent) period will have expired before marketing approvalis obtained from the public health regulatory bodies... (hence) a prolonged period of

protection can be obtained to compensate, at least in part, for this loss of the effective periodof protection. (/T, 2012) and co%panies practice evergreening, in which

pharma(ceutical) companies continuously extend the life of a patent by tweaking the drugslightly.. (ature*co%, 2012)*

or the duration o" patent protection, de4eloping countries are pre4ented "ro% i%porting orproducing (cheaper) generic drugs* s a conse5uence, %any patients %ay &e depri4ed "ro%a""orda&le, potentially li"e-sa4ing %edication*

$hould e+tension &e considered "or %edicine patent protection, at the e+pense o" pu&lic accessto a""orda&le %edicine6 7e&ate your 4ie's, citing credi&le secondary research*

Instructions

1* 8ou are re5uired to 'rite your ans'er 'ithin the 'ord li%it o" 2,000 'ords* Thislimit excludes citations and references* In the e4ent the %a+i%u% 'ord li%its aree+ceeded, any part or parts o" the ans'er in e+cess o" the 'ord li%it 'ill &e disregarded*

2* The "ollo'ing is a general guide as to the report layout9(a) Introduction9 general identi"ication o" the legal issues that 'ill &e discussed:(&) ;ody9 ela&oration o" the legal issues (identi"ied at the Introduction. stage)

and application o" those legal issues: and(c) Conclusion9 su%%ary o" the argu%ents presented and a persuasi4e conclusion*

3* 8our attention is also dra'n to ills in researching and a&ility to articulate a critical appraisal o" issues pertaining to

Intellectual Property protection: and3* pply your >no'ledge in Intellectual Property to address the pro&le% put "orth*

Le4el 2 sia Paci"ic

8/12/2019 Incourse Question(2)

2/2

Intellectual Property, Ethics and Legal Issues [CT031-3-2 IPEL]

Assessment Criteria

This assess%ent 'ill &e %ar>ed &ased on the "ollo'ing criteria9-

CONTENT9 Clarity and "lo' o" in"or%ation and the a&ility to consider thesalient issues 'ithin the constraints o" the 'ord li%it

40 marks

REEARC!9 Bood and &alanced research to'ards critical e4aluation ratherthan plain description* ppropriate and di""erent sources %ust &e re4ie'ed,"ocusing on acade%ic research and not ust secondary research "ro%